Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-15-004885
Filing Date
2015-06-17
Accepted
2015-06-17 17:23:39
Documents
8
Period of Report
2015-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp57199_6k.htm 6-K 16640
2 EXHIBIT 99.1 dp57199_ex9901.htm EX-99.1 14278
3 EXHIBIT 99.2 dp57199_ex9902.htm EX-99.2 13850
4 EXHIBIT 99.3 dp57199_ex9903.htm EX-99.3 28389
5 EXHIBIT 99.4 dp57199_ex9904.htm EX-99.4 20547
6 EXHIBIT 99.5 dp57199_ex9905.htm EX-99.5 10290
7 EXHIBIT 99.6 dp57199_ex9906.htm EX-99.6 4908
8 EXHIBIT 99.7 dp57199_ex9907.htm EX-99.7 5529
  Complete submission text file 0000950103-15-004885.txt   115398
Mailing Address JOUKAHAISENKATU 6 TURKU H9 FI-20520
Business Address JOUKAHAISENKATU 6 TURKU H9 FI-20520 358-2-274-8900
Biotie Therapies Corp. (Filer) CIK: 0001579695 (see all company filings)

EIN.: 000000000 | State of Incorp.: H9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37423 | Film No.: 15937926
SIC: 2834 Pharmaceutical Preparations